OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
批准号:
6490869
负责人:
ROBERT MICHAEL KESSLER
金额:
$35.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-01 至 2003-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Verbatim from the Applicant's Abstract) The antipsychotic effects
of typical neuroleptics are mediated by blockade of dopamine D2 type receptors.
It has been proposed that the antipsychotic effects of these drugs are mediated
by blockade of cortical and limbic dopamine D2 receptors while extrapyramidal
site effects are mediated by dorsolateral striatal D2 receptor blockade. To
date, most PET and SPECT studies of antipsychotic drug blockade of D2 receptors
have examined the striatum. There are a number of studies which suggest that
the atypical profile of clozapine is mediated at least in part by selective
effects on cortical and limbic dopaminergic neurotransmission. Our group has
developed [18F] N-allyl-5-fluoropropylepidepride as a PET radioligand for
visualization of extrastriatal D2 receptors in man. Our Phase I and early Phase
II IND studies demonstrate that this ligand allows excellent visualization and
quantitation of extrastriatal D2 receptors in man. Wed propose to use [18F]
N-allyl-5-fluoropropylepidepride PET studies to evaluate 15 schizophrenic
subjects off medication and following 6 weeks of haloperidol monotherapy, as
well as 15 schizophrenic subjects off medication and following 8 weeks of
clozapine monotherapy. The data from these studies will allow evaluation as to
whether clozapine, s compared to haloperidol (a typical neuroleptic),
selectively occupies extrastriatal dopamine D2 receptors, and whether regional
occupancy of D2 receptors can be related to antipsychotic effects. Secondary
goals include examining if psychopathological symptom complexes, i.e.,
positive, negative, and disorganization, as well as cognitive abnormalities in
schizophrenia are related to regional levels of D2 receptors.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.neuroimage.2009.01.049
发表时间:
2009-05-15
期刊:
NeuroImage
影响因子:
5.7
作者:
[Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM]
通讯作者:
Kessler RM
DOI:
10.1176/ajp.2006.163.9.1639
发表时间:
2006-09
期刊:
The American journal of psychiatry
影响因子:
--
作者:
[Patrizia Riccardi;D. Zald;Rui Li;Sohee Park;M. S. Ansari;B. Dawant;S. Anderson;N. Woodward;D. Schmidt;R. Baldwin;R. Kessler]
通讯作者:
Patrizia Riccardi;D. Zald;Rui Li;Sohee Park;M. S. Ansari;B. Dawant;S. Anderson;N. Woodward;D. Schmidt;R. Baldwin;R. Kessler
DOI:
10.1002/syn.20822
发表时间:
2011-02
期刊:
SYNAPSE
影响因子:
2.3
作者:
[Riccardi, Patrizia, Park, Sohee, Anderson, Sharlet, Doop, Mikisha, Ansari, M. Sib, Schmidt, Dennis, Baldwin, Ronald]
通讯作者:
Baldwin, Ronald
DOI:
10.1016/j.biopsych.2008.12.029
发表时间:
2009-06-15
期刊:
BIOLOGICAL PSYCHIATRY
影响因子:
10.6
作者:
[Kessler, Robert M., Woodward, Neil D., Riccardi, Patrizia, Li, Rui, Ansari, M. Sib, Anderson, Sharlett, Dawant, Benoit, Zald, David, Meltzer, Herbert Y.]
通讯作者:
Meltzer, Herbert Y.
DOI:
10.1016/j.neuroimage.2010.02.006
发表时间:
2010-05-15
期刊:
NEUROIMAGE
影响因子:
5.7
作者:
[Zald, David H., Woodward, Neil D., Cowan, Ronald L., Riccardi, Patrizia, Ansari, M. Sib, Baldwin, Ronald M., Cowan, Ronald L., Smith, Clarence E., Hakyemez, Helene, Li, Rui, Kessler, Robert M.]
通讯作者:
Kessler, Robert M.
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:8841983
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:9304643
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
[18F] FPEB Studies of the mGluR5 Receptor and Methamphetamine Abuse
-
批准号:9763544
-
项目类别:
-
资助金额:$48.96万
-
财政年份:2014
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7731405
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2006
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7605580
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2006
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
PET IMAGING OF EXTRASTRIATAL DOPAMINE LEVELS
-
批准号:7375659
-
项目类别:
-
资助金额:$0.25万
-
财政年份:2005
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6945829
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Small Animal PET Scanner
-
批准号:6581711
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6678142
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
Pet Imaging of Extrastriatial Dopamine Levels
-
批准号:6800018
-
项目类别:
-
资助金额:$16.99万
-
财政年份:2003
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
-
批准号:6039159
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2000
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
OCCUPANCY OF EXTRASTRIATAL D2 RECEPTORS BY CLOZAPINE
-
批准号:6343768
-
项目类别:
-
资助金额:$34.04万
-
财政年份:2000
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:2247333
-
项目类别:
-
资助金额:$20.37万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386766
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386764
-
项目类别:
-
资助金额:$15.38万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
D2 RECEPTORS IN SCHIZOPHRENIA: OPTIMIZED PET LIGANDS
-
批准号:3386765
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1990
-
负责人:ROBERT MICHAEL KESSLER
-
依托单位:
海外基金